Literature DB >> 27592379

Hydrophobic bile acids suppress expression of AE2 in biliary epithelial cells and induce bile duct inflammation in primary biliary cholangitis.

Satomi Hisamoto1, Shinji Shimoda2, Kenichi Harada3, Sho Iwasaka4, Shinya Onohara5, Yong Chong6, Minoru Nakamura7, Yuki Bekki8, Tomoharu Yoshizumi9, Toru Ikegami10, Yoshihiko Maehara11, Xiao-Song He12, M Eric Gershwin13, Koichi Akashi14.   

Abstract

Understanding the mechanisms of chronic inflammation in primary biliary cholangitis (PBC) is essential for successful treatment. Earlier work has demonstrated that patients with PBC have reduced expression of the anion exchanger 2 (AE2) on biliary epithelial cells (BEC) and deletion of AE2 gene has led to a PBC-like disorder in mice. To directly address the role of AE2 in preventing PBC pathogenesis, we took advantage of our ability to isolate human BEC and autologous splenic mononuclear cells (SMC). We studied the influence of hydrophobic bile acids, in particular, glycochenodeoxycholic acid (GCDC), on AE2 expression in BEC and the subsequent impact on the phenotypes of BEC and local inflammatory responses. We demonstrate herein that GCDC reduces AE2 expression in BEC through induction of reactive oxygen species (ROS), which enhances senescence of BEC. In addition, a reduction of AE2 levels by either GCDC or another AE2 inhibitor upregulates expression of CD40 and HLA-DR as well as production of IL-6, IL-8 and CXCL10 from BEC in response to toll like receptor ligands, an effect suppressed by inhibition of ROS. Importantly, reduced AE2 expression enhances the migration of autologous splenic mononuclear cells (SMC) towards BEC. In conclusion, our data highlight a key functional role of AE2 in the maintenance of the normal physiology of BEC and the pathogenic consequences of reduced AE2 expression, including abnormal intrinsic characteristics of BEC and their production of signal molecules that lead to the chronic inflammatory responses in small bile ducts.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autoimmune cholangitis; Cholangiocytes; Cytokine; Inflammation

Mesh:

Substances:

Year:  2016        PMID: 27592379     DOI: 10.1016/j.jaut.2016.08.006

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  23 in total

Review 1.  Myeloid Cells and Chronic Liver Disease: a Comprehensive Review.

Authors:  Min Lian; Carlo Selmi; M Eric Gershwin; Xiong Ma
Journal:  Clin Rev Allergy Immunol       Date:  2018-04       Impact factor: 8.667

2.  A Practical Review of Primary Biliary Cholangitis for the Gastroenterologist.

Authors:  Fernanda Q Onofrio; Gideon M Hirschfield; Aliya F Gulamhusein
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-03

Review 3.  Environmental basis of primary biliary cholangitis.

Authors:  Atsushi Tanaka; Patrick Sc Leung; M Eric Gershwin
Journal:  Exp Biol Med (Maywood)       Date:  2018-01-07

4.  The fingerprint of antimitochondrial antibodies and the etiology of primary biliary cholangitis.

Authors:  Zongwen Shuai; Jinjun Wang; Madhu Badamagunta; Jinjung Choi; Guoxiang Yang; Weici Zhang; Thomas P Kenny; Kathryn Guggenheim; Mark J Kurth; Aftab A Ansari; John Voss; Ross L Coppel; Pietro Invernizzi; Patrick S C Leung; M Eric Gershwin
Journal:  Hepatology       Date:  2017-03-31       Impact factor: 17.425

Review 5.  Pathogen infections and primary biliary cholangitis.

Authors:  A Tanaka; P S C Leung; M E Gershwin
Journal:  Clin Exp Immunol       Date:  2018-09-17       Impact factor: 4.330

Review 6.  Primary biliary cholangitis: a comprehensive overview.

Authors:  Ana Lleo; Simona Marzorati; Juan-Manuel Anaya; M Eric Gershwin
Journal:  Hepatol Int       Date:  2017-11-21       Impact factor: 6.047

7.  MicroRNA-506 promotes primary biliary cholangitis-like features in cholangiocytes and immune activation.

Authors:  Oihane Erice; Patricia Munoz-Garrido; Javier Vaquero; Maria J Perugorria; Maite G Fernandez-Barrena; Elena Saez; Alvaro Santos-Laso; Ander Arbelaiz; Raul Jimenez-Agüero; Joaquin Fernandez-Irigoyen; Enrique Santamaria; Verónica Torrano; Arkaitz Carracedo; Meenakshisundaram Ananthanarayanan; Marco Marzioni; Jesus Prieto; Ulrich Beuers; Ronald P Oude Elferink; Nicholas F LaRusso; Luis Bujanda; Jose J G Marin; Jesus M Banales
Journal:  Hepatology       Date:  2018-02-21       Impact factor: 17.425

Review 8.  Dietary and metabolic modulators of hepatic immunity.

Authors:  Antonella Carambia; Johannes Herkel
Journal:  Semin Immunopathol       Date:  2017-11-06       Impact factor: 9.623

9.  Endogenous IL-10 maintains immune tolerance but IL-10 gene transfer exacerbates autoimmune cholangitis.

Authors:  Yu-Hsin Hsueh; Hung-Wen Chen; Bi-Jhen Syu; Chia-I Lin; Patrick S C Leung; M Eric Gershwin; Ya-Hui Chuang
Journal:  J Autoimmun       Date:  2018-09-28       Impact factor: 7.094

Review 10.  AIM associated with the IgM pentamer: attackers on stand-by at aircraft carrier.

Authors:  Toru Miyazaki; Tomoko Yamazaki; Ryoichi Sugisawa; M Eric Gershwin; Satoko Arai
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.